NXSNF Stock Research

Today

CoreWeave price target raised by $5 at JPMorgan, here's why

CRWV

7:57 AM

Jazz Pharmaceuticals price target raised by $3 at Morgan Stanley, here's why

JAZZ

7:57 AM

Axsome Therapeutics price target raised by $9 at Morgan Stanley, here's why

AXSM

7:56 AM

Paysign price target raised by $4 at Barrington, here's why

PAYS

7:56 AM

GoPro price target lowered by 80c at Morgan Stanley, here's why

GPRO

7:55 AM

TaskUs price target raised by $1 at Morgan Stanley, here's why

TASK

7:54 AM

N-able price target lowered by $2.25 at BMO Capital, here's why

NABL

7:54 AM

Neuronetics reports Q2 EPS (5c), consensus (12c)

STIM

7:54 AM

Ventas price target raised by $2 at BMO Capital, here's why

7:52 AM

Signet appoints Jamie Cygielman as president of Zales, Banter

7:51 AM

Eikon Therapeutics announces dose selection for TeLuRide-006 trial

EIKN

7:50 AM

Target price target raised by $20 at BMO Capital, here's why

7:50 AM

Bicara CEO Claire Mazumdar to switch roles, Ryan Cohlhepp to succeed

BCAX

7:49 AM

Dollar Tree price target raised by $8 at BMO Capital, here's why

DLTR

7:48 AM

Rocket Pharmaceuticals price target lowered by $1 at Wedbush, here's why

RCKT

7:48 AM

Boeing just upgraded at Argus, here's why

7:48 AM

Arena Group just downgraded at Lake Street, here's why

AREN

7:47 AM

Jade Biosciences price target raised by $2 at Wedbush, here's why

JBIO

7:46 AM

Surgery Partners price target raised by $2 at TD Cowen, here's why

SGRY

7:46 AM

Vera Therapeutics price target lowered by $9 at Wedbush, here's why

VERA

7:45 AM

Skyward Specialty Insurance price target raised by $16 at TD Cowen, here's why

SKWD

7:45 AM

Quanterix price target lowered by $1 at TD Cowen, here's why

QTRX

7:44 AM

Bicara Therapeutics reports Q2 EPS (82c), consensus (83c)

BCAX

7:44 AM

Applied Materials assumed with a Market Perform at William Blair

AMAT

7:43 AM

Hims & Hers price target raised by $5 at TD Cowen, here's why

HIMS

7:43 AM

Today

CoreWeave price target raised by $5 at JPMorgan, here's why

CRWV

7:57 AM

Jazz Pharmaceuticals price target raised by $3 at Morgan Stanley, here's why

JAZZ

7:57 AM

Axsome Therapeutics price target raised by $9 at Morgan Stanley, here's why

AXSM

7:56 AM

Paysign price target raised by $4 at Barrington, here's why

PAYS

7:56 AM

GoPro price target lowered by 80c at Morgan Stanley, here's why

GPRO

7:55 AM

TaskUs price target raised by $1 at Morgan Stanley, here's why

TASK

7:54 AM

N-able price target lowered by $2.25 at BMO Capital, here's why

NABL

7:54 AM

Neuronetics reports Q2 EPS (5c), consensus (12c)

STIM

7:54 AM

Ventas price target raised by $2 at BMO Capital, here's why

7:52 AM

Signet appoints Jamie Cygielman as president of Zales, Banter

7:51 AM

Eikon Therapeutics announces dose selection for TeLuRide-006 trial

EIKN

7:50 AM

Target price target raised by $20 at BMO Capital, here's why

7:50 AM

Bicara CEO Claire Mazumdar to switch roles, Ryan Cohlhepp to succeed

BCAX

7:49 AM

Dollar Tree price target raised by $8 at BMO Capital, here's why

DLTR

7:48 AM

Rocket Pharmaceuticals price target lowered by $1 at Wedbush, here's why

RCKT

7:48 AM

Boeing just upgraded at Argus, here's why

7:48 AM

Arena Group just downgraded at Lake Street, here's why

AREN

7:47 AM

Jade Biosciences price target raised by $2 at Wedbush, here's why

JBIO

7:46 AM

Surgery Partners price target raised by $2 at TD Cowen, here's why

SGRY

7:46 AM

Vera Therapeutics price target lowered by $9 at Wedbush, here's why

VERA

7:45 AM

Skyward Specialty Insurance price target raised by $16 at TD Cowen, here's why

SKWD

7:45 AM

Quanterix price target lowered by $1 at TD Cowen, here's why

QTRX

7:44 AM

Bicara Therapeutics reports Q2 EPS (82c), consensus (83c)

BCAX

7:44 AM

Applied Materials assumed with a Market Perform at William Blair

AMAT

7:43 AM

Hims & Hers price target raised by $5 at TD Cowen, here's why

HIMS

7:43 AM

Company News

Charts